Report Detail

Request for Sample of this report

Medical Devices & Consumables Global Hospital-Acquired Pneumonia Prevention Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031

  • RnM4628493
    • |
  • 26 September, 2025
    • |
  • Global
    • |
  • 100 Pages
    • |
  • GIR
    • |
  • Medical Devices & Consumables

According to our (Global Info Research) latest study, the global Hospital-Acquired Pneumonia Prevention market size was valued at US$ 184 million in 2024 and is forecast to a readjusted size of USD 281 million by 2031 with a CAGR of 6.4% during review period.
Dental plaque is a biofilm formed by bacteria and their excreta, mainly distributed between the gums, and these bacteria cannot be removed using gauze or sponges. Bacteria in the mouth will quickly form a bacterial biofilm and cover the surface of the teeth within two hours after each cleaning. This biofilm protects common pathogens in the ICU, such as Staphylococcus aureus and Klebsiella pneumoniae. This biofilm must be destroyed before using antibacterial agents. If plaque and bacteria cannot be removed, they will move down to the balloon of the endotracheal tube. Since the balloon sealing cannot reach 100%, aspiration pneumonia will occur. Oral care is one of the effective means to prevent hospital-acquired pneumonia.
In hospitals, oral care is a vital measure to prevent aspiration pneumonia (i.e., hospital-acquired pneumonia), especially for bedridden patients, the elderly, patients with weakened immunity, and critically ill patients. This is because if the bacteria in the mouth are not effectively removed, they may enter the lungs through aspiration (i.e., swallowing saliva, food, or oral secretions), thus causing pneumonia. With the advancement of medical technology and the improvement of patients' awareness of hospital infection prevention and control, the prevention measures of hospital-acquired pneumonia have gradually gained attention. Globally, the prevention market of hospital-acquired pneumonia has gradually developed with the changes in public health needs and medical environment. The prevention market of hospital-acquired pneumonia included in this report is mainly oral care products.
Oral care products usually include oral care kits, moisturizing gels, mouthwashes, etc., among which oral care kits accounts for the largest proportion.
From the application point of view, patients in intensive care units (ICUs) are usually in an immunosuppressive state, and the risk of pneumonia infection is higher than that of patients in ordinary wards. Oral care has become an important part of reducing infection and preventing pneumonia. In order to reduce the incidence of hospital-acquired pneumonia in ICU patients, the use of oral care kits has become one of the standard preventive measures. The proportion in 2023 is approximately 60%.
The global key players of HAP prevention include Stryker, Medline, Ecolab, Avanos, Dentsply Sirona, Intersurgical and Dentaid, etc. In 2023, in term of revenue of HAP prevention, the top 3 companies hold a share nearly 43%.
The problem of antibiotic resistance is becoming more and more serious, and traditional antibiotic treatment is no longer the only way to deal with hospital-acquired pneumonia. Preventive measures, such as the use of oral care kits, can effectively reduce bacterial loads and reduce the need for antibiotics, thereby alleviating the problem of drug resistance.
This report is a detailed and comprehensive analysis for global Hospital-Acquired Pneumonia Prevention market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Hospital-Acquired Pneumonia Prevention market size and forecasts, in consumption value ($ Million), sales quantity (M Units), and average selling prices (US$/Unit), 2020-2031
Global Hospital-Acquired Pneumonia Prevention market size and forecasts by region and country, in consumption value ($ Million), sales quantity (M Units), and average selling prices (US$/Unit), 2020-2031
Global Hospital-Acquired Pneumonia Prevention market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (M Units), and average selling prices (US$/Unit), 2020-2031
Global Hospital-Acquired Pneumonia Prevention market shares of main players, shipments in revenue ($ Million), sales quantity (M Units), and ASP (US$/Unit), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Hospital-Acquired Pneumonia Prevention
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Hospital-Acquired Pneumonia Prevention market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Stryker, Medline, Ecolab, Avanos, Dentsply Sirona, Intersurgical, Dentaid, Xttrium, Germiphene, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Hospital-Acquired Pneumonia Prevention market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Oral Care Kit
Moisturizer Gel
Mouth Wash
Others
Market segment by Application
General Ward
Intensive Care Unit
Major players covered
Stryker
Medline
Ecolab
Avanos
Dentsply Sirona
Intersurgical
Dentaid
Xttrium
Germiphene
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Hospital-Acquired Pneumonia Prevention product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Hospital-Acquired Pneumonia Prevention, with price, sales quantity, revenue, and global market share of Hospital-Acquired Pneumonia Prevention from 2020 to 2025.
Chapter 3, the Hospital-Acquired Pneumonia Prevention competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Hospital-Acquired Pneumonia Prevention breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Hospital-Acquired Pneumonia Prevention market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Hospital-Acquired Pneumonia Prevention.
Chapter 14 and 15, to describe Hospital-Acquired Pneumonia Prevention sales channel, distributors, customers, research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Hospital-Acquired Pneumonia Prevention Consumption Value by Type: 2020 Versus 2024 Versus 2031
    • 1.3.2 Oral Care Kit
    • 1.3.3 Moisturizer Gel
    • 1.3.4 Mouth Wash
    • 1.3.5 Others
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Hospital-Acquired Pneumonia Prevention Consumption Value by Application: 2020 Versus 2024 Versus 2031
    • 1.4.2 General Ward
    • 1.4.3 Intensive Care Unit
  • 1.5 Global Hospital-Acquired Pneumonia Prevention Market Size & Forecast
    • 1.5.1 Global Hospital-Acquired Pneumonia Prevention Consumption Value (2020 & 2024 & 2031)
    • 1.5.2 Global Hospital-Acquired Pneumonia Prevention Sales Quantity (2020-2031)
    • 1.5.3 Global Hospital-Acquired Pneumonia Prevention Average Price (2020-2031)

2 Manufacturers Profiles

  • 2.1 Stryker
    • 2.1.1 Stryker Details
    • 2.1.2 Stryker Major Business
    • 2.1.3 Stryker Hospital-Acquired Pneumonia Prevention Product and Services
    • 2.1.4 Stryker Hospital-Acquired Pneumonia Prevention Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.1.5 Stryker Recent Developments/Updates
  • 2.2 Medline
    • 2.2.1 Medline Details
    • 2.2.2 Medline Major Business
    • 2.2.3 Medline Hospital-Acquired Pneumonia Prevention Product and Services
    • 2.2.4 Medline Hospital-Acquired Pneumonia Prevention Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.2.5 Medline Recent Developments/Updates
  • 2.3 Ecolab
    • 2.3.1 Ecolab Details
    • 2.3.2 Ecolab Major Business
    • 2.3.3 Ecolab Hospital-Acquired Pneumonia Prevention Product and Services
    • 2.3.4 Ecolab Hospital-Acquired Pneumonia Prevention Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.3.5 Ecolab Recent Developments/Updates
  • 2.4 Avanos
    • 2.4.1 Avanos Details
    • 2.4.2 Avanos Major Business
    • 2.4.3 Avanos Hospital-Acquired Pneumonia Prevention Product and Services
    • 2.4.4 Avanos Hospital-Acquired Pneumonia Prevention Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.4.5 Avanos Recent Developments/Updates
  • 2.5 Dentsply Sirona
    • 2.5.1 Dentsply Sirona Details
    • 2.5.2 Dentsply Sirona Major Business
    • 2.5.3 Dentsply Sirona Hospital-Acquired Pneumonia Prevention Product and Services
    • 2.5.4 Dentsply Sirona Hospital-Acquired Pneumonia Prevention Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.5.5 Dentsply Sirona Recent Developments/Updates
  • 2.6 Intersurgical
    • 2.6.1 Intersurgical Details
    • 2.6.2 Intersurgical Major Business
    • 2.6.3 Intersurgical Hospital-Acquired Pneumonia Prevention Product and Services
    • 2.6.4 Intersurgical Hospital-Acquired Pneumonia Prevention Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.6.5 Intersurgical Recent Developments/Updates
  • 2.7 Dentaid
    • 2.7.1 Dentaid Details
    • 2.7.2 Dentaid Major Business
    • 2.7.3 Dentaid Hospital-Acquired Pneumonia Prevention Product and Services
    • 2.7.4 Dentaid Hospital-Acquired Pneumonia Prevention Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.7.5 Dentaid Recent Developments/Updates
  • 2.8 Xttrium
    • 2.8.1 Xttrium Details
    • 2.8.2 Xttrium Major Business
    • 2.8.3 Xttrium Hospital-Acquired Pneumonia Prevention Product and Services
    • 2.8.4 Xttrium Hospital-Acquired Pneumonia Prevention Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.8.5 Xttrium Recent Developments/Updates
  • 2.9 Germiphene
    • 2.9.1 Germiphene Details
    • 2.9.2 Germiphene Major Business
    • 2.9.3 Germiphene Hospital-Acquired Pneumonia Prevention Product and Services
    • 2.9.4 Germiphene Hospital-Acquired Pneumonia Prevention Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.9.5 Germiphene Recent Developments/Updates

3 Competitive Environment: Hospital-Acquired Pneumonia Prevention by Manufacturer

  • 3.1 Global Hospital-Acquired Pneumonia Prevention Sales Quantity by Manufacturer (2020-2025)
  • 3.2 Global Hospital-Acquired Pneumonia Prevention Revenue by Manufacturer (2020-2025)
  • 3.3 Global Hospital-Acquired Pneumonia Prevention Average Price by Manufacturer (2020-2025)
  • 3.4 Market Share Analysis (2024)
    • 3.4.1 Producer Shipments of Hospital-Acquired Pneumonia Prevention by Manufacturer Revenue ($MM) and Market Share (%): 2024
    • 3.4.2 Top 3 Hospital-Acquired Pneumonia Prevention Manufacturer Market Share in 2024
    • 3.4.3 Top 6 Hospital-Acquired Pneumonia Prevention Manufacturer Market Share in 2024
  • 3.5 Hospital-Acquired Pneumonia Prevention Market: Overall Company Footprint Analysis
    • 3.5.1 Hospital-Acquired Pneumonia Prevention Market: Region Footprint
    • 3.5.2 Hospital-Acquired Pneumonia Prevention Market: Company Product Type Footprint
    • 3.5.3 Hospital-Acquired Pneumonia Prevention Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Hospital-Acquired Pneumonia Prevention Market Size by Region
    • 4.1.1 Global Hospital-Acquired Pneumonia Prevention Sales Quantity by Region (2020-2031)
    • 4.1.2 Global Hospital-Acquired Pneumonia Prevention Consumption Value by Region (2020-2031)
    • 4.1.3 Global Hospital-Acquired Pneumonia Prevention Average Price by Region (2020-2031)
  • 4.2 North America Hospital-Acquired Pneumonia Prevention Consumption Value (2020-2031)
  • 4.3 Europe Hospital-Acquired Pneumonia Prevention Consumption Value (2020-2031)
  • 4.4 Asia-Pacific Hospital-Acquired Pneumonia Prevention Consumption Value (2020-2031)
  • 4.5 South America Hospital-Acquired Pneumonia Prevention Consumption Value (2020-2031)
  • 4.6 Middle East & Africa Hospital-Acquired Pneumonia Prevention Consumption Value (2020-2031)

5 Market Segment by Type

  • 5.1 Global Hospital-Acquired Pneumonia Prevention Sales Quantity by Type (2020-2031)
  • 5.2 Global Hospital-Acquired Pneumonia Prevention Consumption Value by Type (2020-2031)
  • 5.3 Global Hospital-Acquired Pneumonia Prevention Average Price by Type (2020-2031)

6 Market Segment by Application

  • 6.1 Global Hospital-Acquired Pneumonia Prevention Sales Quantity by Application (2020-2031)
  • 6.2 Global Hospital-Acquired Pneumonia Prevention Consumption Value by Application (2020-2031)
  • 6.3 Global Hospital-Acquired Pneumonia Prevention Average Price by Application (2020-2031)

7 North America

  • 7.1 North America Hospital-Acquired Pneumonia Prevention Sales Quantity by Type (2020-2031)
  • 7.2 North America Hospital-Acquired Pneumonia Prevention Sales Quantity by Application (2020-2031)
  • 7.3 North America Hospital-Acquired Pneumonia Prevention Market Size by Country
    • 7.3.1 North America Hospital-Acquired Pneumonia Prevention Sales Quantity by Country (2020-2031)
    • 7.3.2 North America Hospital-Acquired Pneumonia Prevention Consumption Value by Country (2020-2031)
    • 7.3.3 United States Market Size and Forecast (2020-2031)
    • 7.3.4 Canada Market Size and Forecast (2020-2031)
    • 7.3.5 Mexico Market Size and Forecast (2020-2031)

8 Europe

  • 8.1 Europe Hospital-Acquired Pneumonia Prevention Sales Quantity by Type (2020-2031)
  • 8.2 Europe Hospital-Acquired Pneumonia Prevention Sales Quantity by Application (2020-2031)
  • 8.3 Europe Hospital-Acquired Pneumonia Prevention Market Size by Country
    • 8.3.1 Europe Hospital-Acquired Pneumonia Prevention Sales Quantity by Country (2020-2031)
    • 8.3.2 Europe Hospital-Acquired Pneumonia Prevention Consumption Value by Country (2020-2031)
    • 8.3.3 Germany Market Size and Forecast (2020-2031)
    • 8.3.4 France Market Size and Forecast (2020-2031)
    • 8.3.5 United Kingdom Market Size and Forecast (2020-2031)
    • 8.3.6 Russia Market Size and Forecast (2020-2031)
    • 8.3.7 Italy Market Size and Forecast (2020-2031)

9 Asia-Pacific

  • 9.1 Asia-Pacific Hospital-Acquired Pneumonia Prevention Sales Quantity by Type (2020-2031)
  • 9.2 Asia-Pacific Hospital-Acquired Pneumonia Prevention Sales Quantity by Application (2020-2031)
  • 9.3 Asia-Pacific Hospital-Acquired Pneumonia Prevention Market Size by Region
    • 9.3.1 Asia-Pacific Hospital-Acquired Pneumonia Prevention Sales Quantity by Region (2020-2031)
    • 9.3.2 Asia-Pacific Hospital-Acquired Pneumonia Prevention Consumption Value by Region (2020-2031)
    • 9.3.3 China Market Size and Forecast (2020-2031)
    • 9.3.4 Japan Market Size and Forecast (2020-2031)
    • 9.3.5 South Korea Market Size and Forecast (2020-2031)
    • 9.3.6 India Market Size and Forecast (2020-2031)
    • 9.3.7 Southeast Asia Market Size and Forecast (2020-2031)
    • 9.3.8 Australia Market Size and Forecast (2020-2031)

10 South America

  • 10.1 South America Hospital-Acquired Pneumonia Prevention Sales Quantity by Type (2020-2031)
  • 10.2 South America Hospital-Acquired Pneumonia Prevention Sales Quantity by Application (2020-2031)
  • 10.3 South America Hospital-Acquired Pneumonia Prevention Market Size by Country
    • 10.3.1 South America Hospital-Acquired Pneumonia Prevention Sales Quantity by Country (2020-2031)
    • 10.3.2 South America Hospital-Acquired Pneumonia Prevention Consumption Value by Country (2020-2031)
    • 10.3.3 Brazil Market Size and Forecast (2020-2031)
    • 10.3.4 Argentina Market Size and Forecast (2020-2031)

11 Middle East & Africa

  • 11.1 Middle East & Africa Hospital-Acquired Pneumonia Prevention Sales Quantity by Type (2020-2031)
  • 11.2 Middle East & Africa Hospital-Acquired Pneumonia Prevention Sales Quantity by Application (2020-2031)
  • 11.3 Middle East & Africa Hospital-Acquired Pneumonia Prevention Market Size by Country
    • 11.3.1 Middle East & Africa Hospital-Acquired Pneumonia Prevention Sales Quantity by Country (2020-2031)
    • 11.3.2 Middle East & Africa Hospital-Acquired Pneumonia Prevention Consumption Value by Country (2020-2031)
    • 11.3.3 Turkey Market Size and Forecast (2020-2031)
    • 11.3.4 Egypt Market Size and Forecast (2020-2031)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2020-2031)
    • 11.3.6 South Africa Market Size and Forecast (2020-2031)

12 Market Dynamics

  • 12.1 Hospital-Acquired Pneumonia Prevention Market Drivers
  • 12.2 Hospital-Acquired Pneumonia Prevention Market Restraints
  • 12.3 Hospital-Acquired Pneumonia Prevention Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Hospital-Acquired Pneumonia Prevention and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Hospital-Acquired Pneumonia Prevention
  • 13.3 Hospital-Acquired Pneumonia Prevention Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Hospital-Acquired Pneumonia Prevention Typical Distributors
  • 14.3 Hospital-Acquired Pneumonia Prevention Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Hospital-Acquired Pneumonia Prevention. Industry analysis & Market Report on Hospital-Acquired Pneumonia Prevention is a syndicated market report, published as Global Hospital-Acquired Pneumonia Prevention Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031. It is complete Research Study and Industry Analysis of Hospital-Acquired Pneumonia Prevention market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    		$3,480.00
    		$5,220.00
    		$6,960.00
    		2,690.04
    		4,035.06
    		5,380.08
    		3,239.88
    		4,859.82
    		6,479.76
    		531,361.20
    		797,041.80
    		1,062,722.40
    		293,712.00
    		440,568.00
    		587,424.00
    Credit card Logo
    Sample Question Discount Download PDF

    Related Reports

    Reason to Buy

    • Trusted By Leaders

      Top executives from leading companies purchase research reports from us. 

    • Shop With Confidence

      We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

    • Customer Centric

      Need assistance related to your research requirements? We are just a phone call or an email away.

    • Personalized Solutions

      Our experienced research specialists are here to help you locate the right reports for your need.

    • Secure Checkout

      Shop without being worried about safety & security of your transactions.
      •

    Request for Sample of this report

    Reports and Markets

    mcafree

    Contact Us

    +1-352-353-0818 (US)

    info@reportsandmarkets.com

    Support

    EMAIL US

    Newsletter

    KEEP UP TO DATE ON ALL THE LATEST REPORTS


    maxmind_logo